1 year return (CAGR)
167.23%
Esperion Therapeutics Inc Exchange (NASDAQ, USD)
ESPR
3.18
-0.01 (-0.31%)
HealthcareDrug Manufacturers - Specialty & Generic
Loading...
3 year return (CAGR)
28.18%
5 year return (CAGR)
-30.68%
10 year return (CAGR)
-11.13%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
819.46M
Price/Sales
1.96
Ent value
1.43B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
12.35
EPS growth
-53.87%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.18 |
| Daily high | 3.18 |
| Daily low | 3.18 |
| Daily Volume | 0K |
| All-time high | 115.30 |
| 1y analyst estimate | 3.20 |
| Beta | 1.06 |
| EPS (TTM) | -0.03 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 24 Feb 2026 |
Downside potential
Loading...
Downside potential data
| ESPR | S&P500 | |
| Current price drop from All-time high | -97.24% | -1.02% |
| Highest price drop | -99.37% | -56.47% |
| Date of highest drop | 14 May 2025 | 9 Mar 2009 |
| Avg drop from high | -70.18% | -10.68% |
| Avg time to new high | 56 days | 12 days |
| Max time to new high | 2804 days | 1805 days |
News
No items found